(Q53271609)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

beta-amyloid is different in normal aging and in Alzheimer disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Claudio Canale

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Claudio Russo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Andrea Armirotti

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Angela Bachi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

16

Pierluigi Gambetti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

17

Massimo Tabaton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

William R. Markesbery

15

object named as

William Markesbery

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Alessandra Piccini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Alessandra Gliozzi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Annalisa Relini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Antonella Vitali

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Roberta Borghi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Luca Giliberto

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Angela Cattaneo

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Silvia Torrassa

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Takaomi C Saido

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

English

0 references

publication date

15 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

Journal of Biological Chemistry

5 January 2020

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

280

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

34186-34192

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

Amyloid beta-protein and the genetics of Alzheimer's disease

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

A comparison of beta-amyloid deposition in the medial temporal lobe in sporadic Alzheimer's disease, Down's syndrome and normal elderly brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Diffuse plaques associated with astroglial amyloid beta protein, possibly showing a disappearing stage of senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Identification of normal and pathological aging in prospectively studied nondemented elderly humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Heterogeneity of water-soluble amyloid beta-peptide in Alzheimer's disease and Down's syndrome brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Presenilin-1 mutations in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Monitoring the process of HypF fibrillization and liposome permeabilization by protofibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Soluble amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Variable deposition of amyloid beta-protein (A beta) with the carboxy-terminus that ends at residue valine40 (A beta 40) in the cerebral cortex of patients with Alzheimer's disease: a double-labeling immunohistochemical study with antibodies specifi

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Suppression of alpha-cyano-4-hydroxycinnamic acid matrix clusters and reduction of chemical noise in MALDI-TOF mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Generation of amyloid beta peptide with pyroglutamate at position 3 in primary cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Glu11 site cleavage and N-terminally truncated A beta production upon BACE overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Alzheimer's disease as proteolytic disorders: anabolism and catabolism of beta-amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Toxicity of pyroglutaminated amyloid beta-peptides 3(pE)-40 and -42 is similar to that of A beta1-40 and -42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Biochemical identification of the neutral endopeptidase family member responsible for the catabolism of amyloid beta peptide in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M501694200

21 January 2018

Identifiers

DOI

10.1074/JBC.M501694200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16103127%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference